Follow the people · Insider
Christobel Selecky
Christobel Selecky files insider transactions with the SEC as a director of ImmunityBio (IBRX). We hold 6 disclosed purchases and sales filed since 5 May 2021, 3 of them in the last 90 days.
- Files forIBRX
- Disclosed buys and sells6 in all, 3 in the last 90 days
- Last disclosure6 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 May 2021 — 1 July 2026Director · ImmunityBio (IBRX)42 Form 4 lines · source: SEC Form 4
Everything they disclosed
42 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 35,064 shares of ImmunityBioSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- exercised options over 124,414 shares of ImmunityBioSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- ▼ sold on the open market 159,478 shares of ImmunityBioSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- exercised options over 35,064 shares of ImmunityBio (a derivative holding)SEC Form 46 July 2026Stock Option (right to buy) · traded 1 July 2026 · filed 6 July 2026
- exercised options over 124,414 shares of ImmunityBio (a derivative holding)SEC Form 46 July 2026Stock Option (right to buy) · traded 1 July 2026 · filed 6 July 2026
- exercised options over 32,173 shares of ImmunityBioSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- exercised options over 30,000 shares of ImmunityBio (a derivative holding)SEC Form 41 July 2026Stock Option (right to buy) · traded 29 June 2026 · filed 1 July 2026
- exercised options over 700 shares of ImmunityBio (a derivative holding)SEC Form 41 July 2026Stock Option (right to buy) · traded 30 June 2026 · filed 1 July 2026
- exercised options over 300 shares of ImmunityBio (a derivative holding)SEC Form 41 July 2026Stock Option (right to buy) · traded 30 June 2026 · filed 1 July 2026
- exercised options over 33,549 shares of ImmunityBioSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- exercised options over 30,000 shares of ImmunityBioSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 95,722 shares of ImmunityBioSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- exercised options over 700 shares of ImmunityBioSEC Form 41 July 2026Common Stock · traded 30 June 2026 · filed 1 July 2026
- exercised options over 300 shares of ImmunityBioSEC Form 41 July 2026Common Stock · traded 30 June 2026 · filed 1 July 2026
- ▼ sold on the open market 1,000 shares of ImmunityBioSEC Form 41 July 2026Common Stock · traded 30 June 2026 · filed 1 July 2026
- exercised options over 32,173 shares of ImmunityBio (a derivative holding)SEC Form 41 July 2026Stock Option (right to buy) · traded 29 June 2026 · filed 1 July 2026
- exercised options over 33,549 shares of ImmunityBio (a derivative holding)SEC Form 41 July 2026Stock Option (right to buy) · traded 29 June 2026 · filed 1 July 2026
- was granted 65,600 shares of ImmunityBio (a derivative holding)SEC Form 410 June 2026Stock Option (right to buy) · traded 9 June 2026 · filed 10 June 2026
- exercised options over 25,000 shares of ImmunityBioSEC Form 424 February 2026Common Stock · traded 23 February 2026 · filed 24 February 2026
- ▼ sold on the open market 25,000 shares of ImmunityBioSEC Form 424 February 2026Common Stock · traded 23 February 2026 · filed 24 February 2026
- exercised options over 25,000 shares of ImmunityBio (a derivative holding)SEC Form 424 February 2026Stock Option (right to buy) · traded 23 February 2026 · filed 24 February 2026
- exercised options over 25,000 shares of ImmunityBio (a derivative holding)SEC Form 424 February 2026Stock Option (right to buy) · traded 23 February 2026 · filed 24 February 2026
- exercised options over 25,000 shares of ImmunityBioSEC Form 424 February 2026Common Stock · traded 23 February 2026 · filed 24 February 2026
- ▼ sold on the open market 25,000 shares of ImmunityBioSEC Form 424 February 2026Common Stock · traded 23 February 2026 · filed 24 February 2026
- exercised options over 50,000 shares of ImmunityBioSEC Form 421 January 2026Common Stock · traded 16 January 2026 · filed 21 January 2026
- ▼ sold on the open market 50,000 shares of ImmunityBioSEC Form 421 January 2026Common Stock · traded 16 January 2026 · filed 21 January 2026
- exercised options over 25,000 shares of ImmunityBioSEC Form 421 January 2026Common Stock · traded 20 January 2026 · filed 21 January 2026
- exercised options over 50,000 shares of ImmunityBio (a derivative holding)SEC Form 421 January 2026Stock Option (right to buy) · traded 16 January 2026 · filed 21 January 2026
- exercised options over 25,000 shares of ImmunityBio (a derivative holding)SEC Form 421 January 2026Stock Option (right to buy) · traded 20 January 2026 · filed 21 January 2026
- ▼ sold on the open market 25,000 shares of ImmunityBioSEC Form 421 January 2026Common Stock · traded 20 January 2026 · filed 21 January 2026
- exercised options over 50,000 shares of ImmunityBio (a derivative holding)SEC Form 421 January 2026Stock Option (right to buy) · traded 16 January 2026 · filed 21 January 2026
- exercised options over 25,000 shares of ImmunityBio (a derivative holding)SEC Form 421 January 2026Stock Option (right to buy) · traded 20 January 2026 · filed 21 January 2026
- exercised options over 50,000 shares of ImmunityBioSEC Form 421 January 2026Common Stock · traded 16 January 2026 · filed 21 January 2026
- ▼ sold on the open market 50,000 shares of ImmunityBioSEC Form 421 January 2026Common Stock · traded 16 January 2026 · filed 21 January 2026
- exercised options over 25,000 shares of ImmunityBioSEC Form 421 January 2026Common Stock · traded 20 January 2026 · filed 21 January 2026
- ▼ sold on the open market 25,000 shares of ImmunityBioSEC Form 421 January 2026Common Stock · traded 20 January 2026 · filed 21 January 2026
- was granted 162,786 shares of ImmunityBio (a derivative holding)SEC Form 420 June 2025Stock Option (right to buy) · traded 18 June 2025 · filed 20 June 2025
- was granted 77,633 shares of ImmunityBio (a derivative holding)SEC Form 413 June 2024Stock Option (right to buy) · traded 11 June 2024 · filed 13 June 2024
- was granted 158,263 shares of ImmunityBio (a derivative holding)SEC Form 415 June 2023Stock Option (right to buy) · traded 13 June 2023 · filed 15 June 2023
- was granted 167,937 shares of ImmunityBio (a derivative holding)SEC Form 415 June 2022Stock Option (right to buy) · traded 14 June 2022 · filed 15 June 2022
- was granted 26,064 shares of ImmunityBio (a derivative holding)SEC Form 414 June 2021Stock Option (right to buy) · traded 10 June 2021 · filed 14 June 2021
- was granted 21,873 shares of ImmunityBio (a derivative holding)SEC Form 45 May 2021Stock Option (right to buy) · traded 3 May 2021 · filed 5 May 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.